Melatonin treatment could be a novel therapeutic strategy for diabetic retinopathy.

PMID: 

J Cell Physiol. 2020 Apr 23. Epub 2020 Apr 23. PMID: 32324260

Abstract Title: 

Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathy.

Abstract: 

Diabetic retinopathy (DR) is the most common ocular complication caused by diabetes mellitus and is the main cause of visual impairment in working-age people. Reactive gliosis and pro-inflammatory cytokine production by Müller cells contribute to the progression of DR. Melatonin is a strong anti-inflammatory hormone, mediating the cytoprotective effect of a variety of retinal cells against hyperglycemia. In this study, melatonin inhibited the gliosis activation and inflammatory cytokine production of Müller cellsin both in vitro and in vivo models of DR. The melatonin membrane blocker, Luzindole, invalidated the melatonin-mediated protective effect on Müller cells. Furthermore, melatonin inhibited Müller cell activation and pro-inflammatory cytokine production by upregulating the long noncoding RNA maternally expressed gene 3/miR-204/sirtuin 1 axis. In conclusion, our study suggested that melatonin treatment could be a novel therapeutic strategy for DR.

read more

Published by Taylor Mercado

Health Time is a blog talking about alternative medicines. And a blog founded by Taylor Mercado. She is a biologist and also a herbalist. This blog will help you and giving you tips regarding with herbal medicines.

Leave a comment

Design a site like this with WordPress.com
Get started